Abstract
Secondary neoplasms involving the pancreas are less common than primary neoplasms. The pancreas is rarely the only metastatic site and metastases can reach the pancreas by lymphatic or hematogenous routes. Several tumors have been demonstrated to metastasize to the pancreas; however, there are differences in the prevalence of the various tumor types that colonize the pancreas, depending upon the population considered (autopsy records vs. surgical specimens).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rock J, Bloomston M, Lozanski G, Frankel WL (2012) The spectrum of hematologic malignancies involving the pancreas: potential clinical mimics of pancreatic adenocarcinoma. Am J Clin Pathol 37:414-422
Adsay NV, Andrea A, Basturk O et al (2004) Secondary tumors of the pancreas: an analysis of a surgical and autopsy database and review of the literature. Virchows Arch 444:527-535
Sweeney AD, Fisher WE, Wu MF et al (2010) Value of Pancreatic Resection for Cancer Metastatic to the Pancreas, J Surg Res 160:268-276
Washington K, McDonagh D (1994) Secondary tumors of the gastrointestinal tract: surgical pathologic findings and comparison with autopsy survey. Mod Pathol 8:427-433
Z’graggen K, Fernandez-del Castillo C, Rattner DW et al (1998) Metastases to the pancreas and their surgical extirpation. Arch Surg 133:413-418
Robbins EG II, Franceschi D, Barkin JS (1996) Solitary metastatic tumors to the pancreas: a case report and a review of the literature. Am J Gastroenterol 91:2414-2417
Konstantinidis IT, Dursun A, Zheng H (2010) Metastatic tumors in the pancreas in the modern era. J Am Coll Surg 211:749-753
Moutardier V, Berthet B, Le Treut Y (1993) Metastase pancreatique d’une tumeur de Grawitz. J Chir (Paris) 130:439-440
Altschuler EL, Ray A (1998) Spontaneous regression of a pancreatic metastasis of a renal cell carcinoma. Arch Fam Med 7:516-517
Motzer RJ, Bander NH, Nanus DM (1996) Renal-cell carcinoma. N Engl J Med 335:865-875
Reddy S, Wolfgang CI (2009) The role of surgery in the management of isolated metastases to the pancreas. Lancet Oncol 10:287-293
Kassabian A, Stein J, Jabbour N (2000) Renal cell carcinoma metastatic to the pancreas: a single-institution series and review of the literature. Urology 56:211-215
Sellner F, Tykalsky N, De Santis M et al (2006) Solitary and multiple isolated metastases of clear cell renal carcinoma to the pancreas: an indication for pancreatic surgery. Ann Surg Oncol 13:75-85
Ward Y, Wang W, Woodhouse E et al (2001) Signal pathways which promote invasion and metastasis: critical and distinct contributions of extra-cellular signal-regulated kinase and Ralspecific guanine exchange factor pathways. Mol Cell Biol 21:5958-5969
Hiotis SP, Klimstra DS, Conlon KC, Brennan MF (2002) Results after pancreatic resection for metastatic lesions. Ann Surg Oncol 9:675-679
Le Borgne J, Partensky C, Glemain P et al (2000) Pancreaticoduodenectomy for metastatic ampullary and pancreatic tumors. Hepatogastroenterology 47:540-544
Thompson LD, Heffess CS et al (2000) Renal cell carcinoma to the pancreas in surgical pathology material. Cancer 89:1076-1088
Fabre JM, Rouanet P, Dagues F et al (1995) Various features and surgical approach of solitary pancreatic metastasis from renal cell carcinoma. Eur J Surg Oncol 21:683-686
Tanis PJ, van der Gaag NA, Busch OR et al (2009) Systematic review of pancreatic surgery for metastatic renal cell carcinoma. Br J Surg 96:579-592
Faure JP, Tuech JJ, Richer JP et al (2001) Pancreatic metastasis of renal cell carcinoma: presentation, treatment and survival. J Urol 165:20-22
Law CH, Wei AC, Hanna SS et al (2003) Pancreatic resection for metastatic renal cell carcinoma: presentation, treatment, and outcome. Ann Surg Oncol 10:922-926
Sohn TA, Yeo CJ, Cameron JL et al (2001) Renal cell carcinoma metastatic to the pancreas: results of surgical management. J Gastrointest Surg 5:346-351
Mechó S, Quiroga S, Cuéllar H, Sebastià C (2009) Pancreatic metastasis of renal cell carcinoma: multidetector CT findings. Abdom Imaging 34:385-389
Flath B, Rickes S, Schweigert M et al (2003) Differentiation of pancreatic metastasis of a renal cell carcinoma from primary pancreatic carcinoma by echo-enhanced power Doppler sonography. Pancreatology 3:349-351
Megibow AJ (2003) Secondary pancreatic tumors: imaging. In: Procacci C, Megibow AJ (eds) Imaging of the pancreas. Cystic and rare tumors. Springer-Verlag: Berlin, pp 277-288.
Jenssen E (1952) A metastatic hypernephroma to the pancreas. Acta Chir Scand 104:177-180
Ballarin R, Spaggiari M, Cautero N et al (2011) Pancreatic metastases from renal cell carcinoma: the state of the art. World J Gastroenterol 17:4747-4756
Zerbi A, Ortolano E, Balzano G et al (2008) Pancreatic metastasis from renal cell carcinoma: which patients benefit from surgical resection? Ann Surg Oncol 15:1161-1168
Motzer JR, Mazumdar M, Bacik J et al (1999) Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol 17:2530-2540
Bassi C, Butturini G, Falconi M et al (2003) High recurrence rate after atypical resection for pancreatic metastases from renal cell carcinoma. Br J Surg 90:555-559
Strobel O, Hackert T, Hartwig W et al (2009) Survival data justifies resection for pancreatic metastases. Ann Surg Oncol 16:3340-3349
Reddy S, Edil BH, Cameron JL et al (2008) Pancreatic resection of isolated metastases from nonpancreatic primary cancers. Ann Surg Oncol 15:3199-3206
Butturini G, Bassi C, Falconi M et al (1998) Surgical treatment of pancreatic metastases from renal cell carcinomas. Dig Surg 15:241-246
Motzer RJ, Hutson TE, Tomczak P et al (2007) Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 356:115-124
Motzer RJ, Michaelson MD, Redman BG et al (2006) Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma. J Clin Oncol 24:16-24
Gore ME, Szczylik C, Porta C et al (2009) Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial. Lancet Oncol 10:757-763
Hudes G, Carducci M, Tomczak P et al (2007) Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med 356:2271-2281
Motzer RJ, Escudier B, Oudard S et al (2008) Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial. Lancet 372:449-456
Sonpavde G, Hutson TE, Rini BI (2008) Axitinib for renal cell carcinoma. Expert Opin Investig Drugs 17:741-748
Rini BI, Escudier B, Tomczak P et al (2011) Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial. Lancet 378:1931-1939
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Italia
About this chapter
Cite this chapter
Butturini, G. et al. (2013). Rare Secondary Tumors of the Pancreas. In: Pederzoli, P., Bassi, C. (eds) Uncommon Pancreatic Neoplasms. Updates in Surgery. Springer, Milano. https://doi.org/10.1007/978-88-470-2673-5_15
Download citation
DOI: https://doi.org/10.1007/978-88-470-2673-5_15
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2672-8
Online ISBN: 978-88-470-2673-5
eBook Packages: MedicineMedicine (R0)